Glucagon-like peptide-1 receptor agonist use and violent crime among US adults.
The rapid proliferation of Glucagon-like peptide-1 (GLP-1) receptor agonists, marketed under brand names such as Ozempic and Wegovy, has already fundamentally altered the landscape of metabolic health and obesity treatment…
Medicines Regulator Investigates UK Clinics for Unsubstantiated Peptide Therapy Claims
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched an investigation into UK clinics that are reportedly making medicinal claims for peptide treatments, raising concerns about the legality and…
UK Medicines Regulator Launches Major Investigation into Clinics Making Unsubstantiated Claims for Experimental Peptide Therapies
The Medicines and Healthcare products Regulatory Agency (MHRA) has initiated a sweeping investigation into numerous UK clinics, probing whether they are in breach of the law by promoting experimental, unregulated…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple







